Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 2/20 | 0.39 |
| ▸ | VNN1 | O95497 | 6/20 | 0.36 |
| ▸ | PTK2 | Q05397 | 3/20 | 0.36 |
| ▸ | BTK | Q06187 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 5/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186275 | 0.93 | BTK (0.38) | OPRL1VNN1PTK2BTKCNR2 | |
| SCHEMBL185483 | 0.91 | OPRL1 (0.38) | OPRL1PTK2BTKCNR2FAAH | |
| SCHEMBL185517 | 0.90 | OPRL1 (0.37) | OPRL1PTK2BTKCNR2FAAH | |
| SCHEMBL199266 | 0.89 | OPRL1 (0.36) | OPRL1PTK2BTKCNR2FAAH | |
| SCHEMBL2813172 | 0.89 | HDAC3 (0.42) | OPRL1VNN1PTK2CNR2LRRK2 | |
| SCHEMBL185881 | 0.88 | OPRL1 (0.37) | OPRL1BTKCNR2FAAH | |
| SCHEMBL186561 | 0.86 | OPRL1 (0.36) | OPRL1PTK2BTKCNR2LRRK2 | |
| SCHEMBL186119 | 0.85 | PTK2 (0.37) | PTK2BTKCNR2LRRK2 | |
| SCHEMBL14856844 | 0.85 | METAP2 (0.38) | OPRL1CNR2HDAC1HDAC6 | |
| SCHEMBL185518 | 0.84 | OPRL1 (0.37) | OPRL1CNR2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2401256-A1 | COMPOUNDS AS BRADYKININ B1 ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2012-01-04 | — | — | EP | disclosed |
| WO-2010097372-A1 | COMPOUNDS AS BRADYKININ B1 ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-09-02 | — | — | WO | disclosed |